Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bronchodilator Response To Inhaled Beta-2 Agonist and Anticholinergic Drugs in Children Born Preterm

NCT06110481 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT06110481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06110481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bronchodilator Response To Inhaled Beta-2 Agonist and Anticholinergic Drugs in Children Born Preterm
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 1, 2025
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial hyperreactivity, bronchial obstruction, bronchopulmonary dysplasia, chronic lung disease of newborn, chronic lung disease of prematurity, preterm birth complication, reversible dilatation